MY

Mytos

YC S18 ↗

London, GB · 26 employees · 11 known investors

mytos.bio ↗

Mytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.

Founders & leadership· Y Combinator alumni (S18)

AA

Ali Afsharin𝕏Founder/CEO

IW

Ignacio WillatsinFounder

Investors · 11

Y

Y Combinator✓ verifiedSan Francisco · $500K

AC

Acequia Capital (AceCap)Seattle · $100K – $5M

AR

Artis VenturesSan Francisco · $50K – $25M

DE

Deep Science VenturesLondon

EM

Emles Venture PartnersNew York

IQ

IQ CapitalLondon · $1M – $40M

KI

Kinled HoldingHong Kongvia Patrick Aisher · inferred

PE

Pente CapitalLondon

TB

TBD AngelsNew York

WI

WingPalo Alto · $200K – $20M

BU

Buckley Ventures Management Company LlcreportedNew York · $300Kvia Josh Buckley · inferred